LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 79.34 | 84.90 | 53 | 9051 | 0.0059 | -0.0676 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 79.34 | 84.90 | 1099 | 9051 | 0.1214 | 0.4625 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 79.34 | 84.90 | 1 | 9051 | 0.0001 | -0.4828 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 79.34 | 84.90 | 62 | 9051 | 0.0068 | -0.0456 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 81.05 | 84.90 | 45 | 8863 | 0.0051 | -0.0903 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 81.05 | 84.90 | 1164 | 8863 | 0.1313 | 0.4776 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 81.05 | 84.90 | 1 | 8863 | 0.0001 | -0.4843 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 81.05 | 84.90 | 45 | 8863 | 0.0051 | -0.0903 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 82.75 | 84.90 | 37 | 8621 | 0.0043 | -0.1171 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 82.75 | 84.90 | 1015 | 8621 | 0.1177 | 0.4509 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 82.75 | 84.90 | 1 | 8621 | 0.0001 | -0.4864 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 82.75 | 84.90 | 38 | 8621 | 0.0044 | -0.1136 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 84.45 | 84.90 | 51 | 8254 | 0.0062 | -0.0743 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 84.45 | 84.90 | 1200 | 8254 | 0.1454 | 0.4935 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 84.45 | 84.90 | 1 | 8254 | 0.0001 | -0.4896 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 84.45 | 84.90 | 31 | 8254 | 0.0038 | -0.1415 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 86.16 | 84.90 | 50 | 8141 | 0.0061 | -0.0773 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 86.16 | 84.90 | 1194 | 8141 | 0.1467 | 0.4941 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 86.16 | 84.90 | 1 | 8141 | 0.0001 | -0.4907 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 86.16 | 84.90 | 24 | 8141 | 0.0029 | -0.1746 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 87.86 | 84.90 | 39 | 7680 | 0.0051 | -0.1128 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 87.86 | 84.90 | 1084 | 7680 | 0.1411 | 0.4798 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 87.86 | 84.90 | 1 | 7680 | 0.0001 | -0.4951 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 87.86 | 84.90 | 19 | 7680 | 0.0025 | -0.2057 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 89.57 | 84.90 | 52 | 7494 | 0.0069 | -0.0730 | MN20160318_Q02 | J14 |